Smith & Jones Innovation

Continuing on the theme of friction at this year's Innovation Network Gathering, Bill Illis explained why and how we need to start paying attention to the boring stuff (his words, not mine) to ensure our "plugs fit into our outlets" in research. This is a great way to spend 15 minutes to learn about interoperability, especially if you are working in or on tech and/or research operations. https://lnkd.in/ecj9RyrS

From Transactional to Transformational: Elevating Vendor Relationships in Pharma | Denise N. Bronner, Ph.D. Why is it important to transform vendors from rescuers to partners? 🔗 Watch the full talk on our website: https://lnkd.in/gKkjrWz6 Despite the industry's push for patient-centricity, vendor relationships in pharma often stay transactional. Denise shines a light on this and offers three ways to change the dynamic. How can we foster deeper collaboration between vendors and pharma—and why does it matter? About Denise N. Bronner, Ph.D. Denise N. Bronner, Ph.D., has 15 years of leadership across healthcare and technology, with experience in academia, consulting, pharma, and venture capital. She focuses on global therapy strategies, health equity, and innovation, and has driven initiatives in storytelling and business development. Denise is the founder of Empactful Ventures, LLC, consulting for healthcare startups, and serves on the Clinical Leader editorial board. She holds a Ph.D. in Microbiology & Immunology from the University of Michigan and has a deep commitment to enhancing diversity in STEM fields.

Recently I had the opportunity to talk about digital protocol standards and interoperability at the Innovation Network Gathering (ING) conference.   It was a great forum to build awareness about a topic that I believe is foundational in transforming how clinical studies work.  I’ve been working on protocol digitalization for several years leading the Digital Data Flow (DDF) initiative with a great team at TransCelerate BioPharma Inc., (including Rob DiCicco, Kelsey Jakee, Belinda Griffin Cryan, Stacy Tegan) and an excellent partnership with leaders at CDISC (including Chris Decker, Peter Van Reusel, David Iberson-Hurst). This transformation is happening. Further collaboration with sponsors, CRO's, sites, regulators, patient advocates, tech providers and investors is key to getting to the finish line and achieving industry-wide interoperability. Join our efforts and be part of creating this future. This was my first ING and I found it to be a unique event laser focused on addressing challenges in building human-centric, digitally competent clinical studies. Protocol digitalization based on industry standards is one piece of that puzzle.  Many of the other pieces are covered in the excellent main stage talks by thought leaders now posted by ING (with more coming soon).  Check them out, you'll be glad you did.   Much gratitude and thanks to Jeff Smith, Michelle D. Jones and team at Smith & Jones Innovation for a huge effort getting me prepared for my talk, and for all they do to make the ING a standout clinical research event.   #digitalprotocols  #DDF  https://lnkd.in/eAyhe-iq

We have the technology, resources, and expertise, yet patients are still waiting. How can we reach patients faster and more effectively? Bill Illis highlights that #collaboration and #interoperability are key: https://lnkd.in/gEb5f8gb #ING2024 #patientcentric #clinicaltrials #innovation

“There is a Society for People Interested in the Study of Boring Things…. I’m a big fan of that organization.” — Bill Illis (full talk: https://lnkd.in/gEb5f8gb) —— “This is the best Digital Data Flows talk I’ve ever seen.” — expert viewer at rehearsal —— Bill is working on something that’s so important but far too few people see. I encourage more people to see it.

We have the technology, resources, and expertise, yet patients are still waiting. How can we reach patients faster and more effectively? Bill Illis highlights that #collaboration and #interoperability are key: https://lnkd.in/gEb5f8gb #ING2024 #patientcentric #clinicaltrials #innovation

H/T YPrime Grazia Mohren Drew Bustos Mark Maietta

In the 3 weeks since this exceptional gathering, I've reflected on the tremendous impact of "friends of the good" who are in the arena working tirelessly to help patients and the sites who serve them. Words cannot express my heartfelt gratitude for Jeff Smith and Michelle D. Jones for gifting me the opportunity to share the stage with such esteemed luminaries. It was both a tremendous honor and a humbling experience, and I am still benefitting from waves of inspiration as I reminisce the conversations and remember what is possible. Let us not become weary in doing good, for at the proper time we will reap a harvest if we do not give up!

https://lnkd.in/dCrkCgYT The video is here ⬆️ When I had my first meeting with Michelle and Jeff from Innovation Network Gathering, it was introductions, and then the beginning conversation of what would become my talk. It went something like this: ING: So what do you want to talk about? Me: What do you mean? ING: You can talk about whatever you want. Me: You mean you don’t have, like, a set track or series of topics I should align to? ING: Nope. We want to hear from you. What is something that you’re passionate about? What’s something you can talk about in a way, and bring yourself to in a way, that nobody has before. And with that - my mind was racing, and the next several months led to this video. I’ve given a lot of stage presentations. As a creator of products, I’ve happily shared the work that my teams and I have put our passion and energy into. Sometimes I even get the chance to talk about ways to push the industry forward, and to challenge our status quo. Inside my company, I get to talk to rising leaders about their journey and my own, and how we can support and advocate for one another. The voice I brought to Innovation Network Gathering was one I’ve found through all of those experiences, and in in-depth conversations with friends, and with my kids, and in books and specialty discussions. It’s one that, I hope, gives voice to the frustrations of a clinical trial history that let some of us down. That was not historically inclusive, and so found treatments that better served a narrow view of humanity. And my growing concern that the potentially revolutionary technology at our fingertips with AI, requiring vast amounts of historic data, will find that data lacking to create new solutions that are as inclusive as we deserve. I love our industry. It motivates and inspires me. And it changes lives every day. We owe it to ourselves and to each other to challenge it to improve, and to give a voice to the underrepresented people, and their data, that our history missed.

The future of innovation doesn't look like a lab or an accelerator; it looks more like a garden. It needs sun, because innovation is something you grow, not something you set up and operate like metal. I presented this at the #ING2024. Check it out. https://lnkd.in/eN2G-xap #innovation #strategy #design